Table 1 Effect of tranexamic acid (TXA) on thromboembolic events in the WOMAN trial [13]
|  | TXA (n = 10,033) | Placebo (n = 9985) | RR (95% CI) | P value |
|---|---|---|---|---|
Any thromboembolic event | 30 (0.3%) | 34 (0.3%) | 0.88 (0.54 to 1.43) | 0.603 |
Venous events | 20 (0.2%) | 25 (0.3%) | 0.80 (0.44 to 1.43) | 0.446 |
DVT | 3 (0.03%) | 7 (0.07%) | 0.43 (0.11 to 1.65) | 0.203 |
PE | 17 (0.2%) | 20 (0.2%) | 0.85 (0.44 to 1.61) | 0.611 |
Arterial events | 10 (0.1%) | 9 (0.09%) | 1.11 (0.45 to 2.72) | 0.827 |
Myocardial infarction | 2 (0.02%) | 3 (0.03%) | 0.66 (0.11 to 3.97) | 0.651 |
Stroke | 8 (0.08%) | 6 (0.06%) | 1.33 (0.46 to 3.82) | 0.599 |